William E. Duke - 15 Aug 2025 Form 4 Insider Report for Invivyd, Inc. (IVVD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Aug 2025, 21:25:51 UTC
Prior SEC filing
19 Feb 2025
Next SEC filing
30 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jill Andersen attorney-in-fact for William E. Duke

Key filing fact

William E. Duke filed Form 4 for Invivyd, Inc. (IVVD) on 19 Aug 2025.

Key facts

  • This page summarizes William E. Duke's Form 4 filing for Invivyd, Inc. (IVVD).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 19 Aug 2025, 21:25.

Change

  • Previous filing in this sequence was filed on 19 Feb 2025.
  • Current net transaction value: -$29,808.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001636135 Primary reporting owner

Duke William E.

Relationship
Chief Financial Officer
Address
C/O INVIVYD, INC., 1601 TRAPELO ROAD, SUITE 178, WALTHAM
Signature
/s/ Jill Andersen attorney-in-fact for William E. Duke
Signature date
19 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IVVD transaction

Common Stock

Options Exercise

Transaction value
Shares
+99,000
Change %
Price
Shares after
99,000
Date
15 Aug 2025
Ownership
Direct
Footnotes
F1
IVVD transaction

Common Stock

Sale

Transaction value
$13,012
Shares
-20,013
Change %
-20%
Price
$0.6502
Shares after
78,987
Date
18 Aug 2025
Ownership
Direct
Footnotes
F2, F3
IVVD transaction

Common Stock

Sale

Transaction value
$16,796
Shares
-29,643
Change %
-38%
Price
$0.5666
Shares after
49,344
Date
19 Aug 2025
Ownership
Direct
Footnotes
F2, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IVVD transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-99,000
Change %
-33%
Price
$0.000000
Shares after
201,000
Date
15 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
99,000
Exercise price
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Footnote F2

The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5801 to $0.7134, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5524 to $0.6040, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Footnote F5

This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

SEC remarks

Exhibit 24.1: Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .